Log in

ASX:IMEImExHS Stock Price, Forecast & News

0.00 (0.00 %)
(As of 05/13/2020)
Today's Range
Now: A$0.03
50-Day Range
MA: A$0.04
52-Week Range
Now: A$0.03
Volume2.09 million shs
Average VolumeN/A
Market Capitalization$38.80 million
P/E RatioN/A
Dividend YieldN/A
ImExHS Limited develops software solutions for running and managing radiology facilities in Colombia, Mexico, Peru, Ecuador, Costa Rica, and internationally. It offers Hiruko radiology information system (RIP) that manages the workflow in diagnostic imaging services; Hiruko picture archiving and communication system (PACS), a technologic platform that stores diagnostic images; Hiruko DictaPACS, a solutions for radiology centers; Hiruko TLRad tool used to interconnect with several radiology centers and view the images remotely, as well from mobile devices; and Hiruko MedBurner that automates the burning of CDs or DVDs. The company also provides nuance, a voice recognition system that include Speech Magic 7, SpeechAnyWhere 360, and DRAGON solutions. ImExHS Limited is headquartered in Bogotá, Colombia.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 3.3Dividend Strength: 0.0Insider Behavior: 3.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.26 out of 5 stars

Industry, Sector and Symbol

Industry Software - Application
SectorComputer and Technology
Phone57 1 316 4890



Sales & Book Value

Annual Sales$7.73 million
Cash FlowA$0.01 per share
Book ValueA$0.01 per share



Outstanding Shares1,175,660,032
Market Cap$38.80 million
Next Earnings DateN/A
OptionableNot Optionable

Receive IME News and Ratings via Email

Sign-up to receive the latest news and ratings for IME and its competitors with MarketBeat's FREE daily newsletter.

ImExHS (ASX:IME) Frequently Asked Questions

How were ImExHS's earnings last quarter?

ImExHS Ltd (ASX:IME) announced its earnings results on Thursday, February, 28th. The company reported ($0.01) earnings per share (EPS) for the quarter. View ImExHS's earnings history.

Has ImExHS been receiving favorable news coverage?

News coverage about IME stock has trended extremely positive recently, InfoTrie Sentiment reports. The research group identifies negative and positive press coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. ImExHS earned a media sentiment score of 5.0 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the near term. View the latest news aboutImExHS.

Who are some of ImExHS's key competitors?

Who are ImExHS's key executives?

ImExHS's management team includes the following people:
  • Dr. German Arango, MD, CEO & Director
  • Mr. Tony Thomas, Chief Financial Officer
  • Mr. Andres Vanegas, Chief Sales Officer
  • Dr. Jorge Marin, Chief Medical Officer
  • Mr. Peter G. Webse B.Bus, FGIA, FCIS, FCPA, MAICD, Company Sec. (Age 56)

What is ImExHS's stock symbol?

ImExHS trades on the ASX under the ticker symbol "IME."

What is ImExHS's stock price today?

One share of IME stock can currently be purchased for approximately A$0.03.

How big of a company is ImExHS?

ImExHS has a market capitalization of $38.80 million and generates $7.73 million in revenue each year. ImExHS employs 54 workers across the globe.

What is ImExHS's official website?

The official website for ImExHS is imexhs.com.

How can I contact ImExHS?

The company can be reached via phone at 57 1 316 4890.

This page was last updated on 5/27/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.